Nurse Practitioners No More Likely Than Doctors to Prescribe Inappropriately
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Oct. 23, 2023 -- Nurse practitioners (NPs) are no more likely to prescribe inappropriately than primary care physicians, according to a study published online Oct. 24 in the Annals of Internal Medicine.
Johnny Huynh, from the University of California in Los Angeles, and colleagues compared rates of inappropriate prescribing among 23,669 NPs and 50,060 primary care physicians who wrote prescriptions for 100 or more patients per year. Patients included Medicare Part D beneficiaries aged 65 years or older.
The researchers found that the mean rates of inappropriate prescribing were almost identical for NPs and primary care physicians (crude rates, 1.63 versus 1.69 per 100 prescriptions; adjusted rates, 1.66 and 1.68, respectively; adjusted odds ratio, 0.99; 95 percent confidence interval, 0.97 to 1.01). Among clinicians with the highest and lowest rates of inappropriate prescribing, NPs were overrepresented. Discrepancies in inappropriate prescribing rates across states tended to be larger than discrepancies between practitioners within states .
"The authors' findings add to a long list of empirical work showing that NPs provide equal or better quality of care when compared with their physician colleagues in primary care," Michelle S. Keller, Ph.D., and Catherine A. Sarkisian, M.D., both from the University of California in Los Angeles, write in an accompanying editorial.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.